CD274 and pancreatic ductal adenocarcinoma: Similarly, in a murine model of pancreatic ductal carcinoma, the depletion of FAP+ stromal cells potentiated the antitumor effects of anti-CTLA4 and anti-PD-L1 therapy (24).